ad image

API - Small Molecule

1 / 10
BioDuro
HPAPI

BioDuro Opens Shanghai Laboratory for Highly Potent Compound Synthesis

BioDuro

PR-03-25-NI-07Mar 25, 2025
Meeting the Complex Challenges of Micronization with Experience and Technology
Micronization

Meeting the Complex Challenges of Micronization with Experience and Technology

TJ Higley, MSc, MBA

Microsize

PAO-02-25-CL-17Feb 25, 2025
BioDuro
Peptide

BioDuro Opens New Solid-Phase Peptide Synthesis Scale-up Facility

BioDuro

PR-01-25-NI-11Jan 14, 2025
1cBio
Announcement

1cBio and Alesta Therapeutics Sign Global Deal to Develop a First-in-Class Small Molecule Treatment for Hypophosphatasia

1cBio

PR-01-25-NI-04Jan 08, 2025
Mikart
CDMO

Mikart Adds Nitrogen-Purged Capability to Liquid and Suspension Suites

Mikart

PR-10-24-NI-54Oct 22, 2024
Olon
M&A

Olon Continues its Growth Path and Announces a New Acquistion

Olon

PR-09-24-NI-01Sep 04, 2024
Assessing Developability and Designing Advanceable Formulations from the Start
Developability

Assessing Developability and Designing Advanceable Formulations from the Start

Nazar Elkarim, Ph.D.

Mikart

PAO-09-24-CL-02Aug 26, 2024
Beyond Pills: the Rise of Liquid Suspensions for Complex Formulations
Liquid Suspensions

Beyond Pills: the Rise of Liquid Suspensions for Complex Formulations

Gus LaBella

Mikart

PAO-07-24-CL-04Jul 09, 2024
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
Outsourced Manufacturing

A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing

April Stanley, MS MBA

Nice Insight

PAO-03-24-NI-02Mar 27, 2024
Small Molecule API Discovery and Development Trends
Nice Insight API Report

Small Molecule API Discovery and Development Trends

April Stanley, MS MBA

Nice Insight

PAO-03-24-NI-01Mar 21, 2024
Antheia
Biomanufacturing

Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential Medicines

Antheia

PR-M03-24-02Mar 13, 2024
Olon
High Potency API Suite

Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US

Olon

PR-M02-24-01Feb 05, 2024
Navigating HPLC Method Development: Tips for Success
Chromatography

Navigating HPLC Method Development: Tips for Success

Ransom Jones

Mikart

PAO-12-23-CL-09Jan 17, 2024
Enabling Client Success with Complementary Services Built upon a Strong Chemistry Foundation
Process Chemistry

Enabling Client Success with Complementary Services Built upon a Strong Chemistry Foundation

Jean-Francois Vincent-Rocan, Ph.D.

BIOVECTRA

PAO-12-23-CL-02Dec 13, 2023
Is this Pharma’s Best Kept Secret? Partnering with Australian Companies for Pharmaceutical Development and Manufacturing

Is this Pharma’s Best Kept Secret? Partnering with Australian Companies for Pharmaceutical Development and Manufacturing

Grant Swart

Mayne Pharma Services

PAO-10-23-CL-04Oct 18, 2023
Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores
Modified-Release Drug Formulations

Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores

Donald Loveday, Ph.D.; Bill McCarthy; Doug Hovey

SPI Pharma

PAO-05-23-CL-06Jun 06, 2023
Olon
Biocatalysis

Olon Presents the First Results Announcing to Have Achieved Developing A New Production Process Through Engineering Target Enzyme

Olon

PR-M05-23-02May 10, 2023
Enhanced Solubility through API Processing: Salt and Cocrystal Formation
API

Enhanced Solubility through API Processing: Salt and Cocrystal Formation

Thomas Briel, Ph.D.; David Luedeker, Ph.D.

MilliporeSigma

PAO-05-23-CL-04May 05, 2023
An Introduction to HPAPIs and Cytotoxic Drugs
HPAPIs

An Introduction to HPAPIs and Cytotoxic Drugs

Roots Analysis

PAO-04-23-CL-04Apr 25, 2023
Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy
New R&D Center

Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy

Peng Dai, Ph.D.; Steven Hu, Ph.D.

Asymchem

PAO-02-23-CL-07Mar 09, 2023
1 / 10